Computer-aided detection (CAD) developer Medicsight has filed a 510(k) application to the U.S Food and Drug Administration (FDA) for its ColonCAD image analysis software.
The London-based firm previously received regulatory approval to market ColonCAD in Europe, Canada, Australia, China, and Brazil.
Related Reading
Road to RSNA, CAD, Medicsight, October 30, 2008
Medicsight touts ESGAR colon CAD data, June 19, 2008
Medicsight parent trims net loss, March 18, 2008
Medicsight, Toshiba ink deal, February 14, 2008
Medicsight, Visage Imaging to collaborate, November 25, 2007
Copyright © 2008 AuntMinnie.com